Get the Stockscreener App
2.34
8.24%
-0.21
Pre-market:
2.35
0.01
+0.43%
Sonoma Pharmaceuticals Inc stock is traded at $2.34, with a volume of 237.65K.
It is down -8.24% in the last 24 hours and down -17.61% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$2.55
Open:
$2.49
24h Volume:
237.65K
Relative Volume:
11.83
Market Cap:
$4.05M
Revenue:
$17.72M
Net Income/Loss:
$-3.37M
P/E Ratio:
-1.1482
EPS:
-2.038
Net Cash Flow:
$-3.72M
1W Performance:
-2.50%
1M Performance:
-17.61%
6M Performance:
-42.65%
1Y Performance:
-27.55%
1-Day Range:
$2.31
$2.49
1-Week Range:
$2.31
$2.56
52-Week Range:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
2.34 | 4.05M | 17.72M | -3.37M | -3.72M | -2.038 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Sonoma Pharmaceuticals Launches Advanced Burn Relief Hydrogel in Walmart and CVS Stores Nationwide - AD HOC NEWS
CVS Now Stocking Sonoma Pharmaceuticals' HOCl-Based Burn Relief Hydrogel - GuruFocus
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart - Bitget
Sonoma Pharmaceuticals launches burn relief gel at CVS, Walmart - Investing.com
Burn relief gel for minor burns heads to CVS and Walmart nationwide - Stock Titan
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin - Shreveport Times
Pharma News: What is Sonoma Pharmaceuticals Incs revenue forecastQuarterly Risk Review & Real-Time Stock Price Movement Reports - baoquankhu1.vn
SNOA Technical Analysis & Stock Price Forecast - Intellectia AI
Sonoma Pharmaceuticals launches Aquanil AD product line By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals launches Aquanil AD - TipRanks
Sonoma Pharmaceuticals launches Aquanil AD product line - Investing.com
Sonoma Pharmaceuticals (SNOA) Launches New Aquanil AD Product Li - GuruFocus
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquan - PharmiWeb.com
Fierce Biotech Layoff Tracker 2026: Vistagen trims team 20%; Evotec to lay off 800 - Fierce Biotech
Layoff Tracker: Vistagen, Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds - BioSpace
Performance Recap: Can Sonoma Pharmaceuticals Inc expand into new markets2026 Historical Comparison & Accurate Buy Signal Notifications - baoquankhu1.vn
Street Watch: Will Fuel Tech Inc benefit from geopolitical trends2026 Intraday Action & Expert Approved Trade Ideas - baoquankhu1.vn
SNOA SEC FilingsSonoma Pharmaceu 10-K, 10-Q, 8-K Forms - Stock Titan
SILO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Comparing Sonoma Pharmaceuticals (NASDAQ:SNOA) & Dominari (NASDAQ:DOMH) - Defense World
Why Sonoma Pharmaceuticals Inc. stock is popular among millennialsJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - mfd.ru
Can Sonoma Pharmaceuticals Inc. (O8Z) stock surprise with quarterly resultsWeekly Trade Review & AI Forecasted Entry and Exit Points - mfd.ru
Is Sonoma Pharmaceuticals Inc. currently under institutional pressureMarket Performance Recap & Technical Analysis for Trade Confirmation - mfd.ru
SNOA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Valuation Update: What is Sonoma Pharmaceuticals Incs revenue forecast2025 Price Momentum & Accurate Trade Setup Notifications - baoquankhu1.vn
Scar Treatment Market to Reach US$ 49.2 Bn by 2033 Expands Amid Rising Aesthetic Demand and Technological InnovationPersistence Market Research - PR Newswire UK
Moving Averages: Is Anywhere Real Estate Inc stock forming a cup and handle - baoquankhu1.vn
How Sonoma Pharmaceuticals Inc. (O8Z) stock performs during market turbulenceWeekly Stock Analysis & Risk Managed Investment Signals - mfd.ru
Aug Breakouts: Is Sonoma Pharmaceuticals Inc currently under institutional pressureJuly 2025 Action & Growth Oriented Trade Recommendations - baoquankhu1.vn
Will CAMP stock outperform tech sector in 20252025 Macro Impact & Weekly High Return Stock Forecasts - mfd.ru
What are Sonoma Pharmaceuticals Inc.’s earnings expectationsPortfolio Return Report & Low Risk High Reward Ideas - mfd.ru
Is Sonoma Pharmaceuticals Inc. stock affected by interest rate hikesEarnings Growth Report & Expert Curated Trade Setups - mfd.ru
Will Sonoma Pharmaceuticals Inc. stock go up in YEAROptions Play & AI Forecasted Stock Moves - mfd.ru
Published on: 2026-02-12 16:52:50 - mfd.ru
Can Sonoma Pharmaceuticals Inc. scale operations efficiently2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - mfd.ru
Should you avoid Sonoma Pharmaceuticals Inc. stock right nowEarnings Growth Summary & Risk Adjusted Buy/Sell Alerts - mfd.ru
Hypochlorous Acid Market Size, Share | Growth Forecast [2034] - Fortune Business Insights
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results - ACCESS Newswire
US revenue jumps 98% as Sonoma expands hypochlorous acid line - Stock Titan
Can Sonoma Pharmaceuticals Inc. maintain its current growth rateJuly 2025 Weekly Recap & Daily Chart Pattern Signal Reports - mfd.ru
Scar Treatment Market Expected See Incredible Growth - openPR.com
Why Sonoma Pharmaceuticals Inc. stock could be next big winnerWeekly Market Report & Technical Confirmation Alerts - mfd.ru
Treatment Type Analysis - Market.us
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):